RxDoctor Payments DataLook up a doctor →

David Shimm, MD

Radiation Oncology · Beckley, WVNPI 1770570731

Payments from drug & device makers

$5,497in general payments, 2019–2025

Across 299 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$617
  • Merck$450
  • Daiichi Sankyo Inc.$354
  • AstraZeneca$281
  • Incyte Corporation$272
  • E.r. Squibb & Sons, L.L.C.$266
  • plus $3K from 54 others

What the payments were for

  • Food & beverage$5,42699%
  • Education$711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis37$617
Merck25$450
Daiichi Sankyo Inc.22$354
AstraZeneca(2 entities)15$281
Incyte Corporation14$272
E.r. Squibb & Sons, L.L.C.18$266
Bayer13$209
Astellas Pharma US Inc10$209
Sanofi7$172
AbbVie9$168
Johnson & Johnson9$159
GSK6$150
Fennec Pharmaceuticals, Inc.1$139
Amgen7$123
Seagen Inc.7$104
Genentech USA, Inc.6$98
Puma Biotechnology, Inc.6$94
Eisai Inc.4$89
ADC Therapeutics America, Inc.4$73
AMAG Pharmaceuticals, Inc.4$71
Pfizer3$70
Coherus Oncology, Inc.4$68
Karyopharm Therapeutics Inc.4$68
Takeda Pharmaceuticals U.S.A., Inc.3$61
Beigene USA, Inc.3$60
Bristol Myers Squibb3$58
Blueprint Medicines Corporation3$50
Taiho Oncology, Inc.2$49
Mirati Therapeutics, Inc.2$46
Pharmacyclics LLC, An Abbvie Company3$45
Geron Corporation2$43
Beone Medicines USA, Inc.2$43
Gilead2$41
Adaptive Biotechnologies Corporation2$41
Tersera Therapeutics LLC2$40
Tesaro, Inc.2$33
CTI Biopharma Corp.2$31
Sumitomo Pharma America, Inc.2$29
Alnylam Pharmaceuticals Inc.1$29
Agios Pharmaceuticals, Inc.2$28
Syndax Pharmaceuticals, Inc.1$28
Ipsen Biopharmaceuticals, Inc2$27
AVEO Pharmaceuticals, Inc.2$26
Kyowa Kirin, Inc.1$26
Springworks Therapeutics, Inc.1$26
Progenics Pharmaceuticals, Inc.1$24
Servier Pharmaceuticals LLC1$24
EMD Serono, Inc.2$24
Iovance Biotherapeutics, Inc.1$23
Telix Pharmaceuticals1$23
Sobi, Inc1$22
Regeneron Healthcare Solutions, Inc.1$21
Novocure Inc.1$20
Exelixis Inc.1$18
Foundation Medicine, Inc.1$18
Stemline Therapeutics Inc.1$18
Curium US LLC1$18
Array Biopharma Inc1$17
Rigel Pharmaceuticals, Inc.1$15
Sanofi-aventis U.S. LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,497 in reported general payments places this provider in the 85th percentile of 29 radiation oncology providers in West Virginia.

See all radiation oncology providers in West Virginia

Medicare billing

Part B allowed, 2024
$630,491
Medicare patients
299
Services billed
16,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$408
Tamsulosin Hcl22$106
Gabapentin19$85

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →